Exosome Diagnostics closed its USD 30m Series C

This month, Exosome Diagnostics closed its USD 30m Series C financing round, led by Tiger Partners and Forbion Capital Partners. Along with other investors, btov Partners participated in the oversubscribed round, which should support the company in the commercial expansion of its products in the oncology market.